{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:53:13Z","timestamp":1761893593698},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1053\/sonc.2002.30143","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T23:46:10Z","timestamp":1030232770000},"page":"56-69","source":"Crossref","is-referenced-by-count":45,"special_numbering":"S2","title":["Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma"],"prefix":"10.1053","volume":"29","author":[{"given":"Joy","family":"Mangel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Buckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Imrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Spaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Crump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marciano","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayardo","family":"Perez-Ordonez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Deodhare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Romans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean B","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Pavlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil L","family":"Berinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/sonc.2002.30143_BIB1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approaches to classifying non-Hodgkin's lymphoma: Clinical features of the major subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB2","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: A clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB3","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","article-title":"Mantle cell lymphoma\u2013An entity comes of age","volume":"87","author":"Weisenberger","year":"1996","journal-title":"Blood"},{"issue":"suppl 8","key":"10.1053\/sonc.2002.30143_BIB4","first-page":"49","article-title":"Management of mantle cell lymphoma","volume":"12","author":"Armitage","year":"1998","journal-title":"Oncology (Huntingt)"},{"key":"10.1053\/sonc.2002.30143_BIB5","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood"},{"issue":"suppl 2","key":"10.1053\/sonc.2002.30143_BIB6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/annonc\/8.suppl_2.S109","article-title":"Bcl-1\/cyclin D1 in malignant lymphoma","volume":"8","author":"de Boer","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB7","first-page":"1437","article-title":"Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster","volume":"7","author":"Williams","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.30143_BIB8","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB9","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V90.10.4212","article-title":"Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease","volume":"90","author":"Andersen","year":"1997","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB10","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/sonc.2002.30143_BIB11","first-page":"726","article-title":"An improved method for detection of B-lymphoid clonality by polymerase chain reaction","volume":"5","author":"Deane","year":"1991","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.30143_BIB12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","article-title":"A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories). A Southwest Oncology Group Study","volume":"85","author":"Fisher","year":"1995","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB13","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1200\/JCO.1995.13.11.2819","article-title":"Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group","volume":"13","author":"Teodorovic","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hon.2900070505","article-title":"Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve prognosis","volume":"7","author":"Meusers","year":"1989","journal-title":"Hematol Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB15","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.1998.16.5.1922","article-title":"Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: Results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group","volume":"16","author":"Hiddemann","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0959-8049(97)10056-9","article-title":"Mantle cell lymphoma: Clinical features, treatment and prognosis of 94 patients","volume":"34","author":"Oinonen","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1053\/sonc.2002.30143_BIB17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","article-title":"Patterns of survival in mantle cell lymphoma","volume":"6","author":"Zucca","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","article-title":"Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/sonc.2002.30143_BIB19","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood.V83.10.2829.2829","article-title":"Nonfollicular small B-cell lymphomas: A heterogenous group of patients with distinct clinical features and outcome","volume":"83","author":"Berger","year":"1994","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.30143_BIB20","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1093\/annonc\/8.suppl_1.S103","article-title":"Treatment of mantle-cell lymphomas with the VAD +\/- chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantation","volume":"8","author":"Gressin","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/1096-8652(200007)64:3<190::AID-AJH9>3.0.CO;2-B","article-title":"Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group","volume":"64","author":"Weisenberger","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1053\/sonc.2002.30143_BIB22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.1997.4693273.x","article-title":"The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group","volume":"99","author":"Vandenberghe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/sonc.2002.30143_BIB23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2401121","article-title":"Mantle cell lymphoma: A retrospective study of 121 cases","volume":"12","author":"Samaha","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.30143_BIB24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/JCO.1998.16.1.3","article-title":"Which treatment for mantle-cell lymphoma patients in 1998?","volume":"16","author":"Coiffier","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s002770050545","article-title":"Management of mantle cell lymphoma","volume":"78","author":"Meusers","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1053\/sonc.2002.30143_BIB26","first-page":"1975","article-title":"Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma","volume":"10","author":"Haas","year":"1996","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.30143_BIB27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1023\/A:1008278605751","article-title":"Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma","volume":"8","author":"Ketterer","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1023\/A:1008251301319","article-title":"Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma","volume":"8","author":"Dreger","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bmt.1701033","article-title":"Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy","volume":"21","author":"Kroger","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/sonc.2002.30143_BIB30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1701046","article-title":"High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin's lymphomas: A single center experience on 18 patients","volume":"21","author":"Blay","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/sonc.2002.30143_BIB31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.1998.16.1.13","article-title":"High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle cell lymphoma: No evidence for long term remission","volume":"16","author":"Freedman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.annonc.a059156","article-title":"The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma","volume":"6","author":"Stewart","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bmt.1701400","article-title":"High-dose therapy with stem cell transplantation for mantle cell lymphoma: Results and prognostic factors, a single center experience","volume":"22","author":"Milpied","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/sonc.2002.30143_BIB34","first-page":"464a","article-title":"Autologous stem cell transplantation for mantle cell lymphoma. The experience of the GEL\/TAMO Spanish cooperative group","volume":"92","author":"Conde","year":"1998","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB35","first-page":"459a","article-title":"Autologous and allogeneic stem cell transplantation for poor-risk mantle cell lymphoma: The City of Hope experience","volume":"92","author":"Molina","year":"1998","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB36","first-page":"78","article-title":"Phase II trial of a salvage therapy by DHAP plus high dose chemotherapy and total body irradiation with autologous stem cell transplantation after failure of CHOP-regimen for mantle cell lymphoma","volume":"10","author":"Lefrere","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1702135","article-title":"Efficacy of autologous stem cell transplantation in mantle cell lymphoma: A 3-year follow-up study","volume":"25","author":"Decaudin","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/sonc.2002.30143_BIB38","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB39","first-page":"172a","article-title":"The impact of early stem cell transplantation on the prognosis of mantle cell lymphoma","volume":"94","author":"Dreger","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB41","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","article-title":"European phase II study of Rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma","volume":"18","author":"Foran","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0609.1999.tb01725.x","article-title":"IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: Evaluation of response on 48 patients","volume":"62","author":"Nguyen","year":"1999","journal-title":"Eur J Haematol"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.30143_BIB44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/11.suppl_1.S123","article-title":"The effect of Rituximab on patients with follicular and mantle-cell lymphoma","volume":"11","author":"Ghielmini","year":"2000","journal-title":"Ann Oncol"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.30143_BIB45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/11.suppl_1.S117","article-title":"Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response","volume":"11","author":"Foran","year":"2000","journal-title":"Ann Oncol"},{"issue":"suppl 14","key":"10.1053\/sonc.2002.30143_BIB46","first-page":"115","article-title":"Stem cell function and engraftment is not affected by \u201cin vivo purging\u201d with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma","volume":"26","author":"Buckstein","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB47","first-page":"638a","article-title":"In vivo purging with rituximab during stem cell transplantation for indolent lymphoma","volume":"94","author":"Flinn","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB48","first-page":"351b","article-title":"Mobilization of peripheral stem cells in patients with indolent lymphoma using a combination of MINE with rituximab","volume":"94","author":"Emmanouilides","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2141.2000.02084.x","article-title":"In vivo depletion of B cells using a combination of high-dose cytosine arabinoside\/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma","volume":"109","author":"Voso","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/sonc.2002.30143_BIB50","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","article-title":"Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: Evidence for a role of both chemotherapy and rituximab infusion","volume":"96","author":"Magni","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB51","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB52","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1008380527502","article-title":"Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy","volume":"10","author":"Khouri","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB53","first-page":"836","article-title":"Prednimustine, mitoxantrone (PmM) vs. cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphomas","volume":"10","author":"Unterhalt","year":"1996","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.30143_BIB54","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/JCO.1999.17.2.546","article-title":"Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstr\u00f6m's macroglobulinemia, and mantle-cell lymphoma","volume":"17","author":"Foran","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB55","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2000.18.4.773","article-title":"Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle cell lymphoma","volume":"18","author":"Zinzani","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB56","first-page":"660a","article-title":"NCCTG phase II trial of 2-chlorodeoxyadenosine as initial therapy for mantle cell lymphoma: A well-tolerated treatment with promising activity","volume":"94","author":"Inwards","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.1998.16.2.579","article-title":"Phase II trial of fludarabine monophosphate in patients with mantle cell lymphomas","volume":"16","author":"Decaudin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30143_BIB58","first-page":"482a","article-title":"Does transplantation improve outcome in mantle cell lymphoma? A study from the EBMT","volume":"96","author":"Vandenberghe","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.bmt.1701044","article-title":"Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation","volume":"21","author":"Adkins","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/sonc.2002.30143_BIB60","first-page":"482a","article-title":"Treatment of follicular and mantle cell non-Hodgkin's lymphoma with anti-CD20 antibody rituximab after high-dose chemotherapy with autologous CD34+ enriched peripheral blood stem cell transplantation","volume":"96","author":"Brugger","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB61","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V89.2.724","article-title":"Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting","volume":"89","author":"Corradini","year":"1997","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB62","first-page":"733a","article-title":"Preliminary report of rituximab with intensive chemotherapy for untreated aggressive mantle cell lymphoma","volume":"96","author":"Romaguera","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB63","first-page":"631a","article-title":"Rituxan\/CHOP induction therapy in newly diagnosed patients with mantle cell lymphoma","volume":"94","author":"Howard","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB64","first-page":"439a","article-title":"Significant prolongation of disease free survival in advanced low grade non Hodgkin lymphomas by interferon alpha maintenance","volume":"86","author":"Unterhalt","year":"1995","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB65","first-page":"674a","article-title":"Clinical characteristics and response to chemotherapy of mantle cell lymphomas\u2013Results of a European survey","volume":"88","author":"Hiddemann","year":"1996","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB66","first-page":"791a","article-title":"High frequency of molecular remissions associated with Rituxan or IFN immunotherapy following ASCT for follicular NHL","volume":"96","author":"Buckstein","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB67","first-page":"792a","article-title":"Further evaluation of a sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma","volume":"96","author":"Lefrere","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB68","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V88.6.2228.bloodjournal8862228","article-title":"Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia is associated with improved outcome after bone marrow transplantation","volume":"88","author":"Provan","year":"1996","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB69","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood.V88.9.3314.bloodjournal8893314","article-title":"Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation","volume":"88","author":"Zwicky","year":"1996","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB70","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","article-title":"Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma","volume":"325","author":"Gribben","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/sonc.2002.30143_BIB71","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30143_BIB72","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2000.18.3.527","article-title":"High dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long term clinical and molecular follow-up","volume":"18","author":"Apostolidis","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775402500786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775402500786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T14:57:13Z","timestamp":1581001033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775402500786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0093775402500786"],"URL":"https:\/\/doi.org\/10.1053\/sonc.2002.30143","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}